Mounjaro vs. Ozempic: Choosing Your Weight Loss Solution

Mounjaro vs. Ozempic: Choosing Your Weight Loss Solution

Compare Mounjaro (Zepbound) and Ozempic (Wegovy) for weight loss and savings

When choosing between Mounjaro (tirzepatide) and Ozempic (semaglutide), both used for treating type 2 diabetes and promoting weight loss, it’s essential to understand their differences. This article provides a detailed comparison between the two medications, helping you make an informed decision, especially if you’re considering buying from Canada, where significant savings can be found.

Mechanism of Action: Dual vs. Single Receptor Targeting

One of the most significant differences between Mounjaro and Ozempic lies in their mechanisms of action. Mounjaro is a dual GIP/GLP-1 receptor agonist, meaning it targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action can result in better blood sugar control and enhanced weight loss for some patients.

In contrast, Ozempic is a GLP-1 receptor agonist, focusing solely on the GLP-1 receptor. While still effective, this single-receptor targeting means it may not be as potent as Mounjaro in some areas, especially regarding weight loss.

Ozempic Vs. Mounjaro Comparison Table

CriteriaMounjaro (Tirzepatide)Ozempic (Semaglutide)
Mechanism of ActionDual GIP/GLP-1 receptor agonistGLP-1 receptor agonist
FDA ApprovalType 2 diabetes; under review for weight lossType 2 diabetes; also approved for weight loss (Wegovy)
Starting Dose2.5 mg once weekly0.25 mg once weekly
Typical Maintenance Dose5 mg to 15 mg once weekly0.5 mg or 1 mg once weekly
Side EffectsNausea, diarrhea, vomiting, reduced appetiteNausea, diarrhea, constipation, reduced appetite
Effectiveness (Blood Sugar Control)Strong A1C reduction (up to 2.0%)Moderate to strong A1C reduction (up to 1.5%)
Weight LossSignificant (up to 20% body weight in some trials)Moderate to significant (up to 15% body weight with Wegovy)
Price in Canada (USD)Approx. USD $620 per monthApprox. USD $429 per month

Dosing Ozempic and Mounjaro: A Stepwise Approach

Both Mounjaro and Ozempic require careful titration, meaning patients start with a low dose and gradually increase their dosage based on tolerance and effectiveness.

  • Mounjaro starts at 2.5 mg once weekly and can be increased to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and eventually 15 mg per week, depending on individual needs and goals.
  • Ozempic, on the other hand, starts at 0.25 mg once weekly, increasing to 0.5 mg or 1 mg once weekly as maintenance.

This broader dosing range gives Mounjaro more flexibility, allowing healthcare providers to tailor the treatment more precisely to a patient’s unique needs. If you require a higher dose for blood sugar control or weight loss, Mounjaro might offer more options than Ozempic.

Side Effects: What to Expect

Both medications share similar side effects, including nausea, diarrhea, and reduced appetite. However, the intensity and frequency of these side effects can vary between individuals and medications.

  • Mounjaro is known to cause vomiting and diarrhea more commonly than Ozempic, especially in the early stages of treatment.
  • Ozempic, while also causing nausea and reduced appetite, may lead to constipation more frequently.

These side effects usually diminish over time as your body adjusts to the medication. However, patients with a sensitive stomach might find Ozempic slightly easier to tolerate in the early weeks of treatment.

Effectiveness: Blood Sugar Control and Weight Loss

When it comes to blood sugar control, Mounjaro appears to have the edge. Clinical trials have shown that Mounjaro can reduce A1C levels by up to 2.0%, while Ozempic typically achieves reductions of up to 1.5%. For patients whose primary concern is managing their diabetes, Mounjaro may offer stronger results.

In terms of weight loss, both medications have proven highly effective, but Mounjaro again has the advantage. Patients on Mounjaro have reported weight reductions of up to 20% of their body weight in some studies, compared to up to 15% for Ozempic (Wegovy). If your goal is more significant weight loss, Mounjaro might be the better option.

Which is the Better Price?

Price Comparison: Savings When Buying from Canada

One of the most critical factors for patients, particularly those paying out-of-pocket, is the cost. While both medications are expensive in the United States, purchasing from Canada can result in considerable savings.

  • Mounjaro is priced at approximately USD $620 per month when purchased from Canadian pharmacies.
  • Ozempic costs about USD $429 per pen when purchased from Canadian pharmacies.

Although Mounjaro is more expensive, its dual-action mechanism and potential for more significant weight loss might make it a worthwhile investment for certain patients.

ozempic vs mounjaro

Mounjaro as low as $158.99 per vial (1 week).

How To Order Mounjaro From Canada

1

Create an account online or by calling us at 1-833-209-3705.

2

Securely upload your prescription, email it to support@overthebordermeds.com, or have your prescriber fax it to 1-833-209-3704.

3

Experience the convenience of purchasing Weight Loss Medication directly from our Canadian online pharmacy. By shopping with us, you’ll enjoy significant savings, on the same brand-manufactured medication.

4

Our team is here to support you every step of the way. If you have any questions or need assistance, we are just a call or email away.

FDA Approval and Use Cases

Both Mounjaro and Ozempic are approved for treating type 2 diabetes, but Mounjaro has also recently been approved for weight loss under the name Zepbound. This approval allows Mounjaro to be prescribed specifically for weight management, adding to its versatility as a treatment for both diabetes and obesity.

Similarly, Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is FDA-approved for weight loss. With both medications now having specific formulations for weight loss, patients can choose based on their individual needs.

If weight loss is a priority, Zepbound (Mounjaro) and Wegovy (Ozempic) are both excellent options, with Mounjaro showing slightly more potential for significant weight reduction in clinical trials.

FAQs For Mounjaro Vs. Ozempic

What is better, Ozempic or Mounjaro?

It depends on your health goals. Mounjaro may provide better blood sugar control and more significant weight loss, while Ozempic (Wegovy) is more affordable and has FDA approval for weight loss.

Can you get Mounjaro in Canada?

Yes, Mounjaro is available in Canada and can be purchased at around USD $620 per month with a valid prescription.

How much weight can you lose on Ozempic in 2 months?

Patients can typically lose 5-10% of their body weight within 2 months of taking Ozempic, depending on diet and exercise.

Is Mounjaro approved for weight loss?

Yes, Mounjaro is now approved for weight loss under the name Zepbound. It has demonstrated significant weight loss benefits in clinical trials, making it a strong option for both diabetes management and weight reduction.

Can I switch from Ozempic to Mounjaro?

Yes, it is possible to switch from Ozempic to Mounjaro. Speak with your healthcare provider to determine the appropriate starting dose and transition plan.

What are the cons of taking Mounjaro?

Some cons of Mounjaro include nausea, vomiting, diarrhea, and its higher price compared to other medications like Ozempic.

What is the most weight lost on Ozempic?

In some cases, patients have reported losing up to 15% of their body weight while on Ozempic (Wegovy).

For more detailed information on Mounjaro dosages and guidelines, visit the official Mounjaro website